Summary of project PR001892
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001892. The data can be accessed directly via it's Project DOI: 10.21228/M8572M This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Project ID: | PR001892 |
| Project DOI: | doi: 10.21228/M8572M |
| Project Title: | Lipid analysis of BMS309403-treated myeloma cells in vitro and in vivo |
| Project Summary: | MM.1S Myeloma tumor cells were treated with 50 μM BMS309403 once over 24 hours in vitro or at 5mg/kg X3 per week over 32 days in vivo. In Vivo tumors were made by subcutaneously injecting 1M Luc+/GFP+ MM.1S cells mixed with Matrigel in a 1:1 ratio into the backs of 8-week old, female SCID-Beige. Vehicle (PBS with a matched concentration of 5% DMSO) was used as control for each condition. |
| Institute: | Mainehealth |
| Last Name: | Reagan |
| First Name: | Michaela |
| Address: | 81 Research Drive, Scarborough, ME, Portland, ME, 04074, USA |
| Email: | Michaela.Reagan@mainehealth.org |
| Phone: | (207)396-8196 |
Summary of all studies in project PR001892
| Study ID | Study Title | Species | Institute | Analysis(* : Contains Untargted data) | Release Date | Version | Samples | Download(* : Contains raw data) |
|---|---|---|---|---|---|---|---|---|
| ST003040 | MM.1S Myeloma tumor cells and tumors made by subcutaneously injecting 1M Luc+/GFP+ MM.1S cells treated with 50 μM BMS309403 and Vehicle (PBS with a matched concentration of 5% DMSO) | Homo sapiens | Mainehealth | MS | 2024-03-25 | 1 | 39 | Uploaded data (14.4M)* |
